In Singapore, thyroid cancer is one of the top 10 cancers among women. It affects individuals of all ages and sex but is most frequently diagnosed in women between 30, and 60 years old with females having a four times higher risk. Fortunately, many types of thyroid cancer grow slowly, and respond well to treatment, especially when detected early. Thus the prognosis is favourable.
While thyroid cancer can be a daunting diagnosis, advances in diagnosis, and treatment have significantly improved patient outcomes. With timely intervention, and personalised care, many individuals go on to lead healthy, full lives.
Thyroid cancer is not a single disease but a group of cancers that arise from different types of cells within the thyroid gland. The most common types originate from follicular cells, which are responsible for producing thyroid hormones. Each type varies in how aggressive it is, how it spreads, and how it is treated, as per the table below:
| TYPE | CELL OF ORIGIN | COMMON FEATURES | SPREAD PATTERN | PROGNOSIS |
| Papillary Thyroid Carcinoma (PTC) | Follicular cells | Most common type.Often affects young to middle-aged adults.May present with lymph node swelling. | Spreads via lymphatic system (neck lymph nodes). | Excellent, especially in the early stages. |
| Follicular Thyroid Carcinoma (FTC) | Follicular cells | Slightly older age group.Less likely to involve lymph nodes.May invade blood vessels. | Tends to spread through bloodstream (lungs, bones). | Good, but lower than PTC. |
| Hurthle Cell Carcinoma | Variant of follicular cells (Hurthle cells) | More aggressive.Higher risk of recurrence.Less responsive to radioactive iodine. | May spread locally, and distantly. | Fair, depends on stage. |
| Medullary Thyroid Carcinoma (MTC) | Parafollicular C-cells | Multiple Endocrine Neoplasia type 2 (MEN2).Associated with elevated calcitonin levels.Requires genetic screening.Rare | Spreads to lymph nodes, and distant organs. | Variable, but better if localised. |
| Anaplastic Thyroid Carcinoma (ATC) | Undifferentiated follicular cells | Rare but very aggressive.Rapid growth.Often presents with neck compression symptoms. | Rapid local invasion, and distant spread. | Poor (often advanced at diagnosis) with rapid deterioration. |
The exact cause of thyroid cancer is not always clear. However, a number of factors are known to increase your risk by triggering changes (mutations) in the DNA of thyroid cells. These mutations affect how cells grow, divide, and die, and may cause uncontrolled cell growth, leading to the formation of a cancerous tumour.
These risk factors include:
| CAUSES | HOW IT TRIGGERS THYROID CANCER |
| Genetic mutations (both inherited and acquired) | Thyroid cancer often begins at the molecular level, where genetic mutations alter the behaviour of normal thyroid cells. These mutations can be:Inherited (germline mutations) passed down through families, such as in familial medullary thyroid cancer.Acquired (somatic mutations) that develop over a person’s lifetime due to environmental exposures or unknown factors. Some common mutations seen in thyroid cancer include:RET proto-oncogene mutations (especially in medullary thyroid cancer).BRAF, and RAS mutations (common in papillary thyroid cancer). |
| Family history of thyroid cancer or genetic syndromes | Having a first-degree relative (such as a parent or sibling) with thyroid cancer significantly raises your risk. Sometimes, thyroid cancer is part of a hereditary cancer syndrome, such as: Multiple Endocrine Neoplasia type 2 (MEN2) – associated with mutations in the RET gene. Familial medullary thyroid carcinoma (FMTC) – a non-syndromic inherited form of thyroid cancer. These syndromes predispose individuals to develop thyroid cancer, often at a younger age and in more aggressive forms. |
| Existing thyroid conditions, such as multinodular goitre or Hashimoto’s thyroiditis | Having certain pre-existing thyroid disorders may increase your risk:Multinodular goitre results in multiple nodules forming within the thyroid. While most are benign, the presence of multiple abnormal growths can increase the chance of one becoming malignant. Hashimoto’s thyroiditis is an autoimmune condition that causes chronic inflammation of the thyroid gland. This ongoing inflammation can lead to cellular damage, and abnormal repair processes, increasing the risk of thyroid lymphoma or papillary thyroid cancer. |
| Iodine deficiency or excess | The thyroid relies on iodine to produce hormones. Both too little, and too much iodine can disrupt thyroid function and cell growth: Iodine deficiency can lead to goitre, and stimulate abnormal cell proliferation. Excess iodine, meanwhile, may trigger inflammation or oxidative stress in thyroid cells. These imbalances may contribute to the development of thyroid nodules, some of which carry the risk of becoming cancerous over time. |
| Radiation exposure during childhood | Radiation exposure, particularly to the head, neck or chest area during childhood, is one of the most well-established risk factors for thyroid cancer. Sources of radiation may include: Past radiation therapy for conditions like acne, enlarged tonsil, or lymphoma. Environmental exposure from nuclear accidents. Radiation damages the DNA within thyroid cells, increasing the risk of mutations that lead to cancer. The thyroid gland is especially sensitive to radiation in children, which explains why those exposed early in life have a higher risk. |
Thyroid nodules are common growths or lumps that form within the thyroid gland. These nodules are non-cancerous, and do not pose a serious health risk.
The progression from a benign thyroid cell to thyroid cancer is usually driven by genetic mutations, and abnormal cell growth. Over time, certain mutations may cause the cell to divide uncontrollably, leading to the formation of a malignant tumour.
Some of the factors that may increase the likelihood of a thyroid nodule becoming cancerous include:

Most benign thyroid nodules remain harmless, but it is essential to monitor them through:
In fact, early detection of changes in a thyroid nodule can help identify cancer at its earliest stage, when treatment is most effective.

Thyroid cancer is often silent in its early stages, but as it progresses, the following symptoms may appear:
Several factors may increase your risk of developing thyroid cancer, including:

At The Metabolic Clinic, our endocrinologists use a comprehensive, and targeted approach to accurately diagnose thyroid cancer. This involves a combination of clinical assessment, advanced imaging, and specialised blood tests.
Our evaluation begins with a detailed consultation, and physical examination:
We use imaging tests to examine the thyroid gland in detail, and assess any suspicious nodules or tumour spread:
Blood tests play an important role in both diagnosis, and follow-up care:

Treatment for thyroid cancer is highly individualised. It depends on several factors, including the type, and stage of the cancer, the patient’s age, overall health, and whether the cancer has spread beyond the thyroid gland.
Surgery is often the first-line treatment for most types of thyroid cancer. Where surgical intervention is indicated, a referral will be made to a relevant surgical specialist for further evaluation and treatment.
Radioactive iodine therapy is commonly used after thyroidectomy, especially for papillary, and follicular thyroid cancers if deemed higher risk:
After surgery, patients usually require lifelong thyroid hormone replacement:
This treatment uses high-energy X-rays to target, and destroy cancer cells:
For advanced or treatment-resistant thyroid cancers, such as metastatic medullary or anaplastic thyroid cancers, systemic therapies may be considered:

Being diagnosed with thyroid cancer can feel overwhelming. But it is important to know that most cases are highly treatable, especially when detected early. Many individuals go on to lead full, healthy lives after treatment, with regular monitoring and support. In fact, advancements in medical care mean that effective treatments are available and outcomes are often very positive.
If you have noticed a lump in your neck, changes in your voice or other persistent symptoms, please do not ignore them. Remember, early action can make all the difference.
Schedule an appointment with us today for a thorough evaluation. Your health and peace of mind are our top priorities.
Yes, thyroid cancer can recur, even after successful treatment. Recurrence may happen in the neck or elsewhere in the body. This is why long-term follow-up with your endocrinologist is crucial. Additionally, regular blood tests, and imaging help detect any signs of recurrence early.
If you have had a total thyroidectomy, you will need to take thyroid hormone replacement (levothyroxine) for life. This replaces the hormones your thyroid used to produce, and helps keep your body’s metabolism in balance.
Thyroid cancer involves the uncontrolled growth of abnormal cells, whereas most thyroid conditions, like hypothyroidism, hyperthyroidism or goitres, are non-cancerous, and due to hormonal imbalances or inflammation. Meanwhile, cancer requires specialised treatment, often including surgery, and radioactive iodine therapy.
Most thyroid cancers are not inherited, but some rare types, especially medullary thyroid carcinoma (MTC), may run in families. If you have a family history of thyroid cancer or MEN2 syndromes, genetic counselling, and testing may be recommended.
Thyroid cancer generally has a high survival rate, especially for papillary, and follicular types. According to global data, the 5-year survival rate exceeds 98% for early-stage papillary thyroid cancer. However, outcomes depend on the cancer type, stage, and the individual’s overall health.
While no specific diet can cure thyroid cancer, maintaining a healthy lifestyle, including balanced nutrition, regular exercise, and stress management, can support recovery, and overall well-being.

MBBS (Hons), FRACP (Australia)
Dr Dinesh graduated with honours from Monash University, Melbourne in 2009, receiving the Prince Henry's Prize in Surgery. During his endocrinology training in Melbourne, he won the top registrar award at the Endocrine Society of Australia Clinical Weekend in 2016, followed by securing Australia's only Andrology fellowship in 2017. Upon returning to Singapore, he was the sub-speciality lead for adrenal, pituitary, and bone services at Khoo Teck Puat Hospital and established The Metabolic Bone Clinic.
A passionate educator, he served as Associate Programme Director for Endocrinology at NHG, training the next generation of endocrinologists, and received the NHG Teaching Award for Senior Doctors in 2023. An expert endocrinologist with proficiency in both general and sub-speciality endocrinology, he has an interest in longevity through improving cardiovascular risk, metabolism, bone health, and muscle loss prevention, with the ultimate aim of improving the number of healthy years in one's life.

If you’re not achieving your treatment targets, struggling with weight changes, fatigue, or unexplained symptoms—it’s time to take a deeper look.
Get clarity with a tailored plan built around you and improving your metabolic health.
MONDAY - FRIDAY
8:30 am to 5:30 pm
SATURDAY
8:30 am – 12:30 pm
Closed on Sun and PH
© 2026 The Metabolic Clinic. All rights reserved.